The findings come from a three-year international research project by the European Respiratory Society’s (ERS) task force on clinical exercise testing, which has evaluated the technology and its benefits and provided recommendations on its use for clinicians.
Clinical exercise testing measures the functioning of the heart, lungs and muscles during exercise and is very sensitive to changes in performance – important in chronic conditions where improvements can be small and very slow.
Professor of Sports Science at the University of Leeds and member of the ERS task force, Sue Ward said: “We were asked to review the latest developments in this kind of testing and look at the reasons why physicians should be considering it as a diagnostic tool. It does require expensive equipment and trained staff, but our review showed that the benefits for a large number of patients suffering from chronic conditions can be considerable.”
One of the biggest problems for people suffering from chronic heart and lung disease is an intolerance to exercise – often to the point of struggling to get up out of a chair or to walk across a room without getting breathless. This inability to exercise leads to further problems, such as a loss of body mass and muscle wasting, and can mean a lower life expectancy for the patient.
Clinicians usually attempt to tackle this problem through interventions such as exercise training, drug treatments, additional oxygen or dietary changes, but as the improvements in the patient can be quite small the effectiveness of the treatment is very hard to judge. Clinical exercise testing enables small incremental changes to be measured and so interventions can be properly evaluated and applied for each patient.
The task force also found that, because the indices it uses are very sensitive to change, clinical exercise testing can be used to diagnose certain conditions and diseases and can also have a prognostic value.
Clinical exercise testing has been used in North America, Japan, Italy and Germany since the 1970s and 80s, but is still rare in the UK. Cardiovascular disease remains the UK’s biggest killer, and although death rates have been falling rapidly since the 1970s, rates in the UK are still amongst the highest in Western Europe.
The initial findings from the task force are published in the latest issue of the European Respiratory Journal and will be the subject of a European Respiratory Society monograph later in the year.
Vanessa Bridge | alfa
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences